Genexine
KOSDAQ · Healthcare · ₩111B
₩2,320-2.73%
Price
2475.0원
2325.0원
Jul 24, 26Oct 27, 26
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
RevenueOperating IncomeNet Income
6/'26
Revenue₩972M+134.4%
Operating Income-₩10.5B-16.6%
Net Income-₩26.3B-111.1%
3/'26 vs prev quarter
Company Health
Market Cap₩111B
Operating Margin-797.7%
Cash on Hand259억원23.3% of market cap
Free Cash Flow-407억원-36.7% of market cap
Short Volume 7.0% · as of 26.10.27
Among 37 신약 개발 peers
LowMedianHigh
PSR22.4xmedian 24.0xPBR0.6xmedian 5.2xROE-16.0%median -34.9%
